Back to Search
Start Over
Oxford Biomedica completes acquisition of ABL Europe
- Source :
- GlobeNewswire. January 29, 2024
- Publication Year :
- 2024
-
Abstract
- Oxford Biomedica completes acquisition of ABL Europe Strengthens Oxford Biomedica's position as a global pure-play cell and gene therapy CDMO with multi viral vector capabilities across multiple sites in EU, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.780771456